Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | TET2 | Q6N021 | 6/20 | 0.40 |
| ▸ | KDM4A | O75164 | 2/20 | 0.40 |
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.40 |
| ▸ | KDM2A | Q9Y2K7 | 2/20 | 0.40 |
| ▸ | TET3 | O43151 | 2/20 | 0.40 |
| ▸ | PGK1 | P00558 | 1/20 | 0.39 |
| ▸ | PGK2 | P07205 | 1/20 | 0.39 |
| ▸ | TET1 | Q8NFU7 | 1/20 | 0.37 |
| ▸ | PDE4A | P27815 | 1/20 | 0.37 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.36 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.35 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2059956 | 1.00 | OR51E2 (0.60) | OR51E2SMN1; SMN2LMNAALDH1A1TET2 | |
| SCHEMBL5902879 | 1.00 | OR51E2 (0.60) | OR51E2SMN1; SMN2LMNAALDH1A1TET2 | |
| SCHEMBL6838468 | 1.00 | OR51E2 (0.60) | OR51E2SMN1; SMN2LMNAALDH1A1TET2 | |
| SCHEMBL6839516 | 1.00 | OR51E2 (0.60) | OR51E2SMN1; SMN2LMNAALDH1A1TET2 | |
| SCHEMBL6838473 | 1.00 | OR51E2 (0.60) | OR51E2SMN1; SMN2LMNAALDH1A1TET2 | |
| SCHEMBL16600632 | 0.95 | OR51E2 (0.55) | OR51E2SMN1; SMN2LMNAALDH1A1TET2 | |
| Ethylene Glycol SCHEMBL251841 | 0.95 | OR51E2 (0.55) | OR51E2SMN1; SMN2LMNAALDH1A1TET2 | |
| Phosphoric Acid SCHEMBL28960961 | 0.93 | OR51E2 (0.52) | OR51E2SMN1; SMN2LMNAALDH1A1TET2 | |
| SCHEMBL7538335 | 0.80 | OR51E2 (0.63) | OR51E2SMN1; SMN2TET2KDM4AKDM4C | |
| Glycerin SCHEMBL18763119 | 0.80 | OR51E2 (0.82) | OR51E2SMN1; SMN2LMNAALDH1A1TET2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115094016-B | Recombinant escherichia coli knocked out glucose-6-phosphate isomerase gene and application thereof in production of 1,2,4-butanetriol | 山东大学 | 2024-02-23 | — | — | CN | claimed |
| US-4853084-A | Method for controlling alkaline pulping process | ALEN RAIMO (FI) | 1989-08-01 | — | — | US | claimed |
| CN-119876337-A | High-throughput screening method of 2-keto-3-deoxy-D-xylonate dehydratase mutant library and application of mutant in biosynthesis of alpha-ketoglutarate | 青岛农业大学 | 2025-04-25 | — | — | CN | disclosed |
| CN-119876337-A | High-throughput screening method of 2-keto-3-deoxy-D-xylonate dehydratase mutant library and application of mutant in biosynthesis of alpha-ketoglutarate | 青岛农业大学 | 2025-04-25 | — | — | CN | disclosed |
| CN-116240232-B | Construction method of Weimberg xylose metabolism pathway in acetobacter xylosojae | 天津科技大学 | 2024-11-29 | — | — | CN | disclosed |
| US-20240392329-A1 | MICROORGANISMS AND METHODS FOR THE PRODUCTION OF OXYGENATED COMPOUNDS FROM HEXOSES | BRASKEM S.A. (BR) | 2024-11-28 | — | — | US | disclosed |
| US-12006526-B2 | Microorganisms and methods for the production of oxygenated compounds from hexoses | BRASKEM S.A. (BR) | 2024-06-11 | — | — | US | disclosed |
| CN-114540395-B | Construction method of xylose utilization metabolism in Shewanella | 天津大学（青岛）海洋工程研究院有限公司 | 2023-06-27 | — | — | CN | disclosed |
| CN-116240232-A | Construction method of Weinberg xylose metabolism pathway in acetobacter xylosoxidans | 天津科技大学 | 2023-06-09 | — | — | CN | disclosed |
| US-20230119263-A1 | Pseudomonas mutant strains with enhanced xylose and galactose utilization | UNITED STATES DEPARTMENT OF ENERGY | 2023-04-20 | — | — | US | disclosed |
| US-11286490-B2 | Formation of alkenes through enzymatic dehydration of alkanols | BRASKEM S.A. (BR) | 2022-03-29 | — | — | US | disclosed |
| US-20200283806-A1 | MICROORGANISMS AND METHODS FOR THE PRODUCTION OF OXYGENATED COMPOUNDS FROM HEXOSES | BRASKEM S.A. (BR) | 2020-09-10 | — | — | US | disclosed |
| US-20200048662-A1 | MICROORGANISMS AND METHODS FOR THE CO-PRODUCTION OF ETHYLENE GLYCOL AND ISOBUTENE | BRASKEM SA (BR) | 2020-02-13 | — | — | US | disclosed |
| EP-3426789-A1 | MICROORGANISMS AND METHODS FOR THE CO-PRODUCTION OF ETHYLENE GLYCOL AND THREE CARBON COMPOUNDS | Braskem S.A. (BR) | 2019-01-16 | — | — | EP | disclosed |
| US-20180179558-A1 | MICROORGANISMS AND METHODS FOR THE CO-PRODUCTION OF ETHYLENE GLYCOL AND THREE CARBON COMPOUNDS | BRASKEM S.A. (BR) | 2018-06-28 | — | — | US | disclosed |
| US-20170260551-A1 | MICROORGANISMS AND METHODS FOR THE CO-PRODUCTION OF ETHYLENE GLYCOL AND THREE CARBON COMPOUNDS | BRASKEM S.A. (BR) | 2017-09-14 | — | — | US | disclosed |
| WO-2017156166-A1 | MICROORGANISMS AND METHODS FOR THE CO-PRODUCTION OF ETHYLENE GLYCOL AND THREE CARBON COMPOUNDS | BRASKEM S.A. (BR) | 2017-09-14 | — | — | WO | disclosed |
| US-9546385-B2 | Genetically modified clostridium thermocellum engineered to ferment xylose | ENCHI CORPORATION (US) | 2017-01-17 | — | — | US | disclosed |
| US-20140370561-A1 | GENETICALLY MODIFIED CLOSTRIDIUM THERMOCELLUM ENGINEERED TO FERMENT XYLOSE | MASCOMA CORPORATION (US) | 2014-12-18 | — | — | US | disclosed |
| US-20040254368-A1 | Production of aldoses | MITSUI CHEMICALS, INC. (JP) | 2004-12-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040254368-A1 | Production of aldoses | ALDOA, ADH1C, AKR1C1 | OR51E2 2750/4885SMN1; SMN2 2135/4885LMNA 2588/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.